Vault-13

SPHERA FUNDS MANAGEMENT LTD.

TEL AVIV, L3 · CIK 1496201 · 13F filing filed 2021-08-17

Exempt reporting adviser since 2021 · other (specify)

As an employer

$1.1bn reported value +1.3% vs Q1 2021
121positions
41.4%in top 10
36 new 32 added 31 reduced 73 sold out vs Q1 2021

Options: 8 call positions ($135.4m notional), 5 put positions ($240.8m notional) – listed below, not included above.

This report includes the holdings of 2 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 1,147,673 $68.7m6.24% 6.24% AddedShares held: Q3 2020 820.0k, Q4 2020 690.5k, Q1 2021 960.5k, Q2 2021 1.1m +187.2k +187,200 19.5%
2 JOHNSON & JOHNSON COM JNJ JNJ 405,608 $66.8m6.06% 6.06% ReducedShares held: Q3 2020 380.0k, Q4 2020 338.2k, Q1 2021 453.9k, Q2 2021 405.6k -48.3k -48,292 -10.6%
3 MERCK & CO INC COM MRK MRK 772,601 $60.1m5.45% 5.45% ReducedShares held: Q3 2020 883.8k, Q4 2020 728.8k, Q1 2021 808.8k, Q2 2021 772.6k -36.2k -36,207 -4.5%
4 XENON PHARMACEUTICALS INC COM XENE XENE 276,130 $51.4m4.66% 4.66% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 276.1k
5 SANOFI SPONSORED ADR SNY SNY 843,400 $44.4m4.03% 4.03% ReducedShares held: Q3 2020 1.1m, Q4 2020 0, Q1 2021 997.9k, Q2 2021 843.4k -154.5k -154,500 -15.5%
6 GENERAC HLDGS INC COM GNRC GNRC 104,363 $43.3m3.93% 3.93% ReducedShares held: Q3 2020 67.0k, Q4 2020 105.7k, Q1 2021 105.7k, Q2 2021 104.4k -1.3k -1,300 -1.2%
7 ELI LILLY & CO COM LLY LLY 181,895 $41.7m3.79% 3.79% ReducedShares held: Q3 2020 156.0k, Q4 2020 410.0k, Q1 2021 429.2k, Q2 2021 181.9k -247.3k -247,305 -57.6%
8 ABBVIE INC COM ABBV ABBV 366,194 $41.2m3.74% 3.74% ReducedShares held: Q3 2020 790.0k, Q4 2020 340.0k, Q1 2021 599.5k, Q2 2021 366.2k -233.3k -233,306 -38.9%
9 C4 THERAPEUTICS INC COM STK CCCC CCCC 518,611 $19.6m1.78% 1.78% AddedShares held: Q3 2020 0, Q4 2020 443.8k, Q1 2021 497.1k, Q2 2021 518.6k +21.5k +21,475 4.3%
10 NICE LTD SPONSORED ADR NICE NICE 76,786 $19.0m1.72% 1.72% AddedShares held: Q3 2020 62.5k, Q4 2020 74.5k, Q1 2021 39.5k, Q2 2021 76.8k +37.3k +37,305 94.5%
11 ESSA PHARMA INC COM NEW EPI EPI 648,303 $18.5m1.68% 1.68% AddedShares held: Q3 2020 250.0k, Q4 2020 390.2k, Q1 2021 469.2k, Q2 2021 648.3k +179.1k +179,062 38.2%
12 KORNIT DIGITAL LTD SHS KRNT KRNT 147,793 $18.4m1.67% 1.67% ReducedShares held: Q3 2020 143.4k, Q4 2020 128.4k, Q1 2021 148.4k, Q2 2021 147.8k -588 -588 -0.4%
13 MICROSOFT CORP COM MSFT MSFT 67,536 $18.3m1.66% 1.66% UnchangedShares held: Q3 2020 51.3k, Q4 2020 47.5k, Q1 2021 67.5k, Q2 2021 67.5k
14 KURA ONCOLOGY INC COM KURA KURA 868,886 $18.1m1.64% 1.64% AddedShares held: Q3 2020 359.5k, Q4 2020 471.5k, Q1 2021 717.8k, Q2 2021 868.9k +151.1k +151,135 21.1%
15 ZAI LAB LTD ADR ZLAB ZLAB 97,946 $17.3m1.57% 1.57% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 65.8k, Q2 2021 97.9k +32.2k +32,158 48.9%
16 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 195,117 $16.1m1.46% 1.46% AddedShares held: Q3 2020 0, Q4 2020 31.3k, Q1 2021 137.7k, Q2 2021 195.1k +57.4k +57,445 41.7%
17 FATE THERAPEUTICS INC COM FATE FATE 165,299 $14.3m1.30% 1.30% AddedShares held: Q3 2020 188.0k, Q4 2020 82.0k, Q1 2021 109.8k, Q2 2021 165.3k +55.5k +55,492 50.5%
18 LIVEPERSON INC COM COM 225,000 $14.2m1.29% 1.29% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 260.0k, Q2 2021 225.0k -35.0k -35,000 -13.5%
19 AMAZON COM INC COM AMZN AMZN 4,061 $14.0m1.27% 1.27% AddedShares held: Q3 2020 3.8k, Q4 2020 2.1k, Q1 2021 2.8k, Q2 2021 4.1k +1.3k +1,300 47.1%
20 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 302,965 $13.6m1.23% 1.23% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 202.1k, Q2 2021 303.0k +100.8k +100,831 49.9%
21 VISTAGEN THERAPEUTICS INC COM NEW VTGN VTGN 4,080,673 $12.9m1.17% 1.17% ReducedShares held: Q3 2020 0, Q4 2020 2.7m, Q1 2021 4.2m, Q2 2021 4.1m -96.5k -96,485 -2.3%
22 AUDIOCODES LTD ORD AUDC AUDC 385,194 $12.7m1.16% 1.16% ReducedShares held: Q3 2020 0, Q4 2020 429.0k, Q1 2021 475.6k, Q2 2021 385.2k -90.4k -90,430 -19.0%
23 KYMERA THERAPEUTICS INC COM KYMR KYMR 259,895 $12.6m1.14% 1.14% AddedShares held: Q3 2020 160.0k, Q4 2020 147.7k, Q1 2021 247.5k, Q2 2021 259.9k +12.4k +12,368 5.0%
24 VARONIS SYS INC COM VRNS VRNS 218,013 $12.6m1.14% 1.14% AddedShares held: Q3 2020 180.7k, Q4 2020 165.7k, Q1 2021 138.7k, Q2 2021 218.0k +79.3k +79,338 57.2%
25 ONCORUS INC COM COM 893,548 $12.3m1.12% 1.12% ReducedShares held: Q3 2020 0, Q4 2020 903.1k, Q1 2021 903.1k, Q2 2021 893.5k -9.6k -9,563 -1.1%
26 WEREWOLF THERAPEUTICS INC COM HOWL HOWL 706,294 $12.0m1.09% 1.09% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 706.3k
27 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 634,088 $12.0m1.08% 1.08% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 284.2k, Q2 2021 634.1k +349.9k +349,864 123.1%
28 AFFIMED N V COM COM 1,276,702 $10.9m0.98% 0.98% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.0m, Q2 2021 1.3m +257.7k +257,737 25.3%
29 ALX ONCOLOGY HLDGS INC COM ALXO ALXO 192,728 $10.5m0.96% 0.96% AddedShares held: Q3 2020 182.1k, Q4 2020 133.4k, Q1 2021 130.4k, Q2 2021 192.7k +62.4k +62,377 47.9%
30 TWILIO INC CL A TWLO TWLO 26,500 $10.4m0.95% 0.95% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 26.5k
31 THERAPEUTICS ACQUISITION COR COM CL A COM CL A 1,009,497 $10.4m0.94% 0.94% AddedShares held: Q3 2020 20.0k, Q4 2020 20.0k, Q1 2021 720.0k, Q2 2021 1.0m +289.5k +289,497 40.2%
32 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 378,642 $9.9m0.89% 0.89% NewShares held: Q3 2020 253.0k, Q4 2020 127.3k, Q1 2021 0, Q2 2021 378.6k
33 CAESARSTONE LTD ORD SHS CSTE CSTE 644,146 $9.5m0.86% 0.86% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 535.1k, Q2 2021 644.1k +109.0k +108,998 20.4%
34 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 547,187 $9.4m0.85% 0.85% ReducedShares held: Q3 2020 510.0k, Q4 2020 745.9k, Q1 2021 638.1k, Q2 2021 547.2k -90.9k -90,906 -14.2%
35 META PLATFORMS INC CL A META META 27,000 $9.4m0.85% 0.85% NewShares held: Q3 2020 35.0k, Q4 2020 40.0k, Q1 2021 0, Q2 2021 27.0k
36 SOLAREDGE TECHNOLOGIES INC COM SEDG SEDG 32,200 $8.9m0.81% 0.81% NewShares held: Q3 2020 4.0k, Q4 2020 0, Q1 2021 0, Q2 2021 32.2k
37 INTELLIA THERAPEUTICS INC COM NTLA NTLA 52,550 $8.5m0.77% 0.77% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 52.5k
38 BIOGEN INC COM BIIB BIIB 23,995 $8.3m0.75% 0.75% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 6.8k, Q2 2021 24.0k +17.2k +17,195 252.9%
39 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 832,878 $8.2m0.75% 0.75% UnchangedShares held: Q3 2020 1.6m, Q4 2020 832.9k, Q1 2021 832.9k, Q2 2021 832.9k
40 NAUTILUS BIOTECHNOLOGY INC COM NAUT NAUT 800,000 $8.1m0.73% 0.73% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 800.0k
41 NKARTA INC COM NKTX NKTX 252,478 $8.0m0.73% 0.73% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 101.0k, Q2 2021 252.5k +151.5k +151,472 150.0%
42 SHATTUCK LABS INC COM STTK STTK 274,214 $7.9m0.72% 0.72% AddedShares held: Q3 2020 0, Q4 2020 55.3k, Q1 2021 140.7k, Q2 2021 274.2k +133.5k +133,549 94.9%
43 ONTO INNOVATION INC COM ONTO ONTO 107,548 $7.9m0.71% 0.71% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 125.0k, Q2 2021 107.5k -17.5k -17,452 -14.0%
44 STOKE THERAPEUTICS INC COM STOK STOK 233,135 $7.8m0.71% 0.71% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 150.7k, Q2 2021 233.1k +82.4k +82,406 54.7%
45 DYNE THERAPEUTICS INC COM DYN DYN 369,714 $7.8m0.71% 0.71% ReducedShares held: Q3 2020 70.0k, Q4 2020 100.0k, Q1 2021 450.1k, Q2 2021 369.7k -80.3k -80,350 -17.9%
46 MIRATI THERAPEUTICS INC COM MRTX MRTX 47,309 $7.6m0.69% 0.69% AddedShares held: Q3 2020 33.0k, Q4 2020 29.8k, Q1 2021 29.8k, Q2 2021 47.3k +17.5k +17,530 58.9%
47 BCLS ACQUISITION CORP COM CL A COM CL A 687,900 $7.2m0.66% 0.66% UnchangedShares held: Q3 2020 0, Q4 2020 625.0k, Q1 2021 687.9k, Q2 2021 687.9k
48 BEIGENE LTD SPONSORED ADR ONC ONC 20,900 $7.2m0.65% 0.65% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 20.9k, Q2 2021 20.9k
49 IDEAYA BIOSCIENCES INC COM IDYA IDYA 334,794 $7.0m0.64% 0.64% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 202.0k, Q2 2021 334.8k +132.8k +132,810 65.8%
50 VERINT SYS INC COM VRNT VRNT 150,000 $6.8m0.61% 0.61% NewShares held: Q3 2020 0, Q4 2020 127.0k, Q1 2021 0, Q2 2021 150.0k
51 ALTIMMUNE INC COM NEW ALT ALT 683,395 $6.7m0.61% 0.61% NewShares held: Q3 2020 243.0k, Q4 2020 0, Q1 2021 0, Q2 2021 683.4k
52 NURIX THERAPEUTICS INC COM NRIX NRIX 244,157 $6.5m0.59% 0.59% AddedShares held: Q3 2020 22.5k, Q4 2020 0, Q1 2021 215.1k, Q2 2021 244.2k +29.1k +29,081 13.5%
53 MERUS N V COM MRUS MRUS 286,506 $6.0m0.55% 0.55% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 77.0k, Q2 2021 286.5k +209.5k +209,514 272.1%
54 RESEARCH ALLIANCE CORP II COM CL A COM CL A 600,000 $6.0m0.54% 0.54% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 600.0k, Q2 2021 600.0k
55 ORCHARD THERAPEUTICS PLC ADS ORTX ORTX 1,366,564 $6.0m0.54% 0.54% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.4m, Q2 2021 1.4m
56 ATERIAN INC COM ATER ATER 399,999 $5.9m0.53% 0.53% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 400.0k
57 SUTRO BIOPHARMA INC COM COM 294,825 $5.5m0.50% 0.50% UnchangedShares held: Q3 2020 0, Q4 2020 201.6k, Q1 2021 294.8k, Q2 2021 294.8k
58 ALLOT LTD SHS ALLT ALLT 276,187 $5.5m0.50% 0.50% ReducedShares held: Q3 2020 1.0m, Q4 2020 533.2k, Q1 2021 420.2k, Q2 2021 276.2k -144.0k -144,018 -34.3%
59 ARS PHARMACEUTICALS INC COM SPRY SPRY 173,891 $5.4m0.49% 0.49% AddedShares held: Q3 2020 0, Q4 2020 174.3k, Q1 2021 167.8k, Q2 2021 173.9k +6.1k +6,092 3.6%
60 ARYA SCIENCES ACQU CORP IV CL A CL A 500,000 $5.4m0.49% 0.49% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 500.0k, Q2 2021 500.0k
61 UNIQURE NV SHS QURE QURE 172,000 $5.3m0.48% 0.48% NewShares held: Q3 2020 126.0k, Q4 2020 216.0k, Q1 2021 0, Q2 2021 172.0k
62 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 801,256 $5.2m0.48% 0.48% UnchangedShares held: Q3 2020 1.0m, Q4 2020 1.0m, Q1 2021 801.3k, Q2 2021 801.3k
63 FIVERR INTL LTD ORD SHS FVRR FVRR 21,500 $5.2m0.47% 0.47% NewShares held: Q3 2020 57.3k, Q4 2020 0, Q1 2021 0, Q2 2021 21.5k
64 INHIBRX INC COM INBX INBX 189,083 $5.2m0.47% 0.47% AddedShares held: Q3 2020 0, Q4 2020 43.2k, Q1 2021 114.6k, Q2 2021 189.1k +74.4k +74,440 64.9%
65 CURIS INC COM NEW COM NEW 588,264 $4.7m0.43% 0.43% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 885.8k, Q2 2021 588.3k -297.6k -297,574 -33.6%
66 CVRX INC COM CVRX CVRX 150,000 $4.2m0.38% 0.38% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 150.0k
67 SUNRUN INC COM RUN RUN 72,000 $4.0m0.36% 0.36% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 72.0k
68 I MAB SPONSORED ADS NBP NBP 46,350 $3.9m0.35% 0.35% ReducedShares held: Q3 2020 181.8k, Q4 2020 181.8k, Q1 2021 55.0k, Q2 2021 46.4k -8.6k -8,612 -15.7%
69 SIGILON THERAPEUTICS INC COM COM 360,239 $3.9m0.35% 0.35% ReducedShares held: Q3 2020 0, Q4 2020 567.5k, Q1 2021 362.2k, Q2 2021 360.2k -2.0k -2,000 -0.6%
70 BEAM THERAPEUTICS INC COM BEAM BEAM 28,425 $3.7m0.33% 0.33% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 28.4k
71 PLAYTIKA HLDG CORP COM PLTK PLTK 150,000 $3.6m0.32% 0.32% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 150.0k
72 ARKO CORP COM ARKO ARKO 369,875 $3.4m0.31% 0.31% ReducedShares held: Q3 2020 0, Q4 2020 600.0k, Q1 2021 408.0k, Q2 2021 369.9k -38.1k -38,125 -9.3%
73 ANNEXON INC COM ANNX ANNX 148,318 $3.3m0.30% 0.30% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 148.3k
74 EUCRATES BIOMEDICAL ACQU COR SHS SHS 329,025 $3.2m0.29% 0.29% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 304.0k, Q2 2021 329.0k +25.0k +25,000 8.2%
75 IVERIC BIO INC COM OPHT OPHT 500,000 $3.2m0.29% 0.29% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 500.0k
76 REPARE THERAPEUTICS INC COM RPTX RPTX 100,391 $3.1m0.28% 0.28% ReducedShares held: Q3 2020 245.0k, Q4 2020 224.3k, Q1 2021 248.1k, Q2 2021 100.4k -147.7k -147,709 -59.5%
77 GRACELL BIOTECHNOLOGIES INC SPONSORED ADS SPONSORED ADS 233,850 $3.0m0.28% 0.28% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 212.6k, Q2 2021 233.8k +21.2k +21,250 10.0%
78 CYCLACEL PHARMACEUTICALS INC COM COM 508,322 $3.0m0.27% 0.27% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 508.3k, Q2 2021 508.3k
79 TREMOR INTL LTD ADS ADS 150,000 $3.0m0.27% 0.27% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 150.0k
80 VINCERX PHARMA INC COM NEW COM NEW 227,450 $3.0m0.27% 0.27% AddedShares held: Q3 2020 0, Q4 2020 46.5k, Q1 2021 93.7k, Q2 2021 227.4k +133.7k +133,742 142.7%
81 SENTINELONE INC CL A S S 68,400 $2.9m0.26% 0.26% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 68.4k
82 PMV PHARMACEUTICALS INC COM PMVP PMVP 84,074 $2.9m0.26% 0.26% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 43.4k, Q2 2021 84.1k +40.7k +40,718 93.9%
83 ACHILLES THERAPEUTICS PLC SPONSORED ADS SPONSORED ADS 292,194 $2.9m0.26% 0.26% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 300.0k, Q2 2021 292.2k -7.8k -7,806 -2.6%
84 ARGENX SE SPONSORED ADR ARGX ARGX 9,249 $2.8m0.25% 0.25% UnchangedShares held: Q3 2020 10.3k, Q4 2020 9.2k, Q1 2021 9.2k, Q2 2021 9.2k
85 FREQUENCY THERAPEUTICS INC COM COM 275,160 $2.7m0.25% 0.25% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 275.2k
86 CYTEIR THERAPEUTICS INC COM COM 125,000 $2.7m0.24% 0.24% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 125.0k
87 PERRIGO CO PLC SHS PRGO PRGO 52,500 $2.4m0.22% 0.22% NewShares held: Q3 2020 71.6k, Q4 2020 0, Q1 2021 0, Q2 2021 52.5k
88 TWIST BIOSCIENCE CORP COM TWST TWST 18,000 $2.4m0.22% 0.22% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 18.0k
89 CEREVEL THERAPEUTICS HLDNG I *W EXP 06/09/202 *W EXP 06/09/202 165,295 $2.4m0.22% 0.22% ReducedShares held: Q3 2020 0, Q4 2020 166.3k, Q1 2021 166.3k, Q2 2021 165.3k -1.0k -1,037 -0.6%
90 CENTURY THERAPEUTICS INC COM IPSC IPSC 80,000 $2.3m0.21% 0.21% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 80.0k
91 LAVA THERAPEUTICS NV SHS LVTX LVTX 215,359 $2.3m0.21% 0.21% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 213.9k, Q2 2021 215.4k +1.5k +1,465 0.7%
92 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 100,000 $2.3m0.21% 0.21% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
93 TURMERIC ACQUISITION CORP CL A CL A 219,440 $2.2m0.20% 0.20% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 219.4k, Q2 2021 219.4k
94 JIYA ACQUISITION CORP COM CL A COM CL A 199,028 $2.0m0.18% 0.18% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 199.0k, Q2 2021 199.0k
95 HEALTHCOR CATALIO ACQU CORP CL A SHS HYPR HYPR 200,000 $2.0m0.18% 0.18% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 200.0k, Q2 2021 200.0k
96 HEALTHCARE CAPITAL CORP UNIT 12/31/2025 UNIT 12/31/2025 196,610 $2.0m0.18% 0.18% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 400.0k, Q2 2021 196.6k -203.4k -203,390 -50.9%
97 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 150,000 $1.7m0.15% 0.15% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 150.0k
98 WIX COM LTD SHS WIX WIX 5,700 $1.7m0.15% 0.15% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 5.7k, Q2 2021 5.7k
99 PLIANT THERAPEUTICS INC COM PLRX PLRX 51,000 $1.5m0.13% 0.13% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 51.0k
100 SINGULAR GENOMICS SYSTEMS IN COM COM 53,867 $1.5m0.13% 0.13% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 53.9k

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
BRISTOL-MYERS SQUIBB CO BMY BMY 200,000 $12.6m200.0k shares
PALO ALTO NETWORKS INC PANW PANW 32,300 $10.4m32.3k shares
BOLT BIOTHERAPEUTICS INC 241,000 $7.9m241.0k shares
ZENTALIS PHARMACEUTICALS INC ZNTL ZNTL 175,140 $7.6m175.1k shares
MOHAWK GROUP HLDGS INC 251,015 $7.4m251.0k shares
TRILLIUM THERAPEUTICS INC TR TR 670,459 $7.2m670.5k shares
CYBERARK SOFTWARE LTD CYBR CYBR 55,000 $7.1m55.0k shares
COGENT BIOSCIENCES INC COGT COGT 762,569 $6.7m762.6k shares
KALVISTA PHARMACEUTICALS INC KALV KALV 258,880 $6.7m258.9k shares
IONIS PHARMACEUTICALS INC IONS IONS 145,476 $6.5m145.5k shares
ARYA SCIENCES ACQUISITION CO NAUT NAUT 400,000 $5.5m400.0k shares
BAIDU INC BIDU BIDU 25,000 $5.4m25.0k shares
RADA ELECTR INDS LTD RADA RADA 407,925 $4.9m407.9k shares
REINVENT TECHNOLOGY PARTNERS 468,012 $4.7m468.0k shares
CELLDEX THERAPEUTICS INC NEW CLDX CLDX 220,320 $4.5m220.3k shares
MEREO BIOPHARMA GROUP PLC MREO MREO 1,312,415 $4.4m1.3m shares
FARFETCH LTD FTCHQ FTCHQ 80,000 $4.2m80.0k shares
ORIC PHARMACEUTICALS INC ORIC ORIC 169,900 $4.2m169.9k shares
FORESIGHT ACQUISITION CORP 420,000 $4.2m420.0k shares
INFLARX NV IFRX IFRX 1,000,000 $3.9m1.0m shares
CATABASIS PHARMACEUTICALS IN CATB CATB 1,294,000 $3.7m1.3m shares
EDGEWISE THERAPEUTICS INC EWTX EWTX 100,000 $3.2m100.0k shares
LONGVIEW ACQUISITION CORP II 300,000 $3.0m300.0k shares
GALERA THERAPEUTICS INC 323,348 $2.9m323.3k shares
GALECTO INC GLTO GLTO 448,016 $2.7m448.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Put XBIPut 625,000 $84.6m625.0k shares New
MERCK & CO INC MRK · Put MRKPut 772,600 $60.1m772.6k shares New
ENPHASE ENERGY INC ENPH · Call ENPHCall 230,000 $42.2m230.0k shares Unchanged
ISHARES TR IGV · Put IGVPut 105,000 $41.0m105.0k shares Added
SELECT SECTOR SPDR TR XLK · Put XLKPut 210,000 $31.0m210.0k shares New
ISHARES TR IWM · Put IWMPut 105,000 $24.1m105.0k shares Reduced
FIVERR INTL LTD FVRR · Call FVRRCall 79,000 $19.2m79.0k shares Reduced
TEVA PHARMACEUTICAL INDS LTD Call Call 1,910,000 $18.9m1.9m shares Added
INVESCO EXCH TRADED FD TR II TAN · Call TANCall 210,000 $18.8m210.0k shares New
BIOGEN INC BIIB · Call BIIBCall 50,000 $17.3m50.0k shares New
IONIS PHARMACEUTICALS INC IONS · Call IONSCall 186,600 $7.4m186.6k shares New
AGIOS PHARMACEUTICALS INC AGIO · Call AGIOCall 116,000 $6.4m116.0k shares New
ATERIAN INC ATER · Call ATERCall 355,600 $5.2m355.6k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-05 PMN 7.8% +2.3 pts 13G 2026-02-05
TENAX THERAPEUTICS INC TENX · 13G · filed 2026-10-13 TENX 7.1%≈ $38.8m +1.8 pts 13G 2026-10-13

Trades reported as a company insider in Q2 2021

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2021-05-04 WEREWOLF THERAPEUTICS INC 10% owner · See footnote HOWL Bought 475,000 $7.6m475.0k shares +152%